AU6263999A - Human genes and gene expression products - Google Patents

Human genes and gene expression products

Info

Publication number
AU6263999A
AU6263999A AU62639/99A AU6263999A AU6263999A AU 6263999 A AU6263999 A AU 6263999A AU 62639/99 A AU62639/99 A AU 62639/99A AU 6263999 A AU6263999 A AU 6263999A AU 6263999 A AU6263999 A AU 6263999A
Authority
AU
Australia
Prior art keywords
gene expression
expression products
human genes
genes
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62639/99A
Other languages
English (en)
Inventor
Radomir Crkvenjakov
Mark Dickson
Radoje Drmanac
Snezana Drmanac
Jaime Escobedo
Pablo Dominguez Garcia
Veronica Garcia
Klaus Giese
Michael A. Innis
Lee William Jones
Altaf Kassam
Giulia C. Kennedy
David Kita
Ivan Labat
George Lamson
Dena Leshkowitz
David Pot
Filippo Randazzo
Christoph Reinhard
Birjit Stache-Crain
Julie Sudduth-Klinger
Lewis T. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Hyseq Inc
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of AU6263999A publication Critical patent/AU6263999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU62639/99A 1998-09-28 1999-09-23 Human genes and gene expression products Abandoned AU6263999A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US10218098P 1998-09-28 1998-09-28
US10216198P 1998-09-28 1998-09-28
US60102180 1998-09-28
US60102161 1998-09-28
US10238098P 1998-09-29 1998-09-29
US60102380 1998-09-29
US10381598P 1998-10-08 1998-10-08
US60103815 1998-10-08
US10587798P 1998-10-27 1998-10-27
US60105877 1998-10-27
PCT/US1999/022226 WO2000018916A2 (fr) 1998-09-28 1999-09-23 Genes humains et produits d'expression genique

Publications (1)

Publication Number Publication Date
AU6263999A true AU6263999A (en) 2000-04-17

Family

ID=27537030

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62639/99A Abandoned AU6263999A (en) 1998-09-28 1999-09-23 Human genes and gene expression products

Country Status (4)

Country Link
EP (1) EP1144636A2 (fr)
JP (1) JP2003530816A (fr)
AU (1) AU6263999A (fr)
WO (1) WO2000018916A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
US6511834B1 (en) 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
GB0106782D0 (en) * 2001-03-19 2001-05-09 Univ The Glasgow Polypeptides, methods and means
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
WO2004016733A2 (fr) 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
DE102004023187A1 (de) * 2004-05-11 2005-12-01 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
EP3112474A1 (fr) * 2015-06-29 2017-01-04 Evonik Degussa GmbH Procédé de détection d'entérite nécrotique aviaire

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
WO1999033982A2 (fr) * 1997-12-23 1999-07-08 Chiron Corporation Genes humains et produits d'expression genique i

Also Published As

Publication number Publication date
JP2003530816A (ja) 2003-10-21
EP1144636A2 (fr) 2001-10-17
WO2000018916A2 (fr) 2000-04-06
WO2000018916A3 (fr) 2000-11-16

Similar Documents

Publication Publication Date Title
AU4187499A (en) Human genes and gene expression products v
AU4053699A (en) Novel human genes and gene expression products
AU2095599A (en) Human genes and gene expression products i
AU6069300A (en) Novel human genes and gene expression products
AU2001285047A1 (en) Human genes and gene expression products
AU2001245619A1 (en) Human genes and gene expression products
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AUPP249298A0 (en) Synthetic genes and genetic constructs comprising same I
AU6037199A (en) Rac-like genes from maize and methods of use
AU6503299A (en) High-beta-conglycinin products and their use
AU5730896A (en) Fucosyltransferase genes and uses thereof
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AU6418498A (en) Human genes
AU4803997A (en) Polymorphisms and new genes in the region of the human hemochromatosis gene
AU2002327607A1 (en) Human genes and gene expression products isolated from human prostate
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
IL136826A0 (en) Essential bacterial genes and their use
AU1101901A (en) Human fgf-20 gene and gene expression products
AU4329300A (en) Human mesenchymal dnas and expression products
AU6263999A (en) Human genes and gene expression products
AU2001226922A1 (en) Cancer associated genes and their products
AU2001287269A1 (en) Human genes and expression products
AU3133799A (en) Seed-coat promoters, genes and gene products
AU3457899A (en) Blk genes, gene products and uses thereof in apoptosis
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase